Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 2.1M | $3.2M | 0% | Sep 2025 |
|
| Citadel Advisors | 53k | $83k | -23% | Sep 2025 |
|
| Royal Bank of Canada | 44k | $69k | 100% | Sep 2025 |
|
| Jones Financial Companies, L.L | 400.00 | $636.000000 | 0% | Sep 2025 |
|
Who sold out of Lava Therapeutics Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2025 | 2.5M | $4.0M |
| BML Capital Management | Sep 2025 | 2.0M | $3.1M |
| Sanofi | Sep 2025 | 1.9M | $3.0M |
| Merck & Co | Sep 2025 | 1.1M | $1.8M |
| Gts Securities | Sep 2025 | 200k | $312k |
| Rangeley Capital | Sep 2025 | 165k | $257k |
| Susquehanna International | Sep 2025 | 154k | $241k |
| Pnc Financial Services | Sep 2025 | 65k | $101k |
| Two Sigma Investments | Jun 2025 | 34k | $45k |
| Lepercq De Neuflize Asset Management | Sep 2025 | 31k | $48k |
| Equitec Proprietary Markets | Sep 2025 | 28k | $44k |
| JBF Capital | Sep 2025 | 24k | $37k |
| XTX Topco | Sep 2025 | 22k | $34k |
| UBS Group | Sep 2025 | 16k | $24k |
| Torno Capital | Sep 2025 | 15k | $23k |
| Geode Capital Management | Sep 2025 | 14k | $22k |
| Jane Street | Sep 2025 | 13k | $20k |
| TSFG | Sep 2025 | 400.00 | $1.0k |
| SBI Securities | Sep 2025 | 300.00 | $468.000000 |